Click on image to view larger version.
FIGURE 4. A 45-y-old man with NHL underwent 18F-FDG PET before (A), after first cycle of (B), and at completion of (C) chemotherapy. Pretherapy 18F-FDG PET images reveal radiotracer uptake in nasopharynx and left cervical lymph nodes. Patient underwent chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone. Both after first cycle and at completion of chemotherapy, 18F-FDG PET reveals no evidence of residual disease. Disease was still in remission after PFS of 18 mo. All images show physiologic uptake in heart.
